4019 alpha-helical domain in beta-lactamase/transpeptidase-like proteins
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 143 | 33.6 | 4.26× | q < 0.0001 | |
| Benzenoids | 41 | 15.9 | 2.58× | q < 0.0001 | |
| Organoheterocyclic compounds | 70 | 33.4 | 2.10× | q < 0.0001 | |
| Organic nitrogen compounds | 12 | 6.9 | 1.73× | q = 0.12 | |
| Homogeneous non-metal compounds | 63 | 46.7 | 1.35× | q = 0.02 | |
| Organic oxygen compounds | 34 | 43.2 | 0.79× | q = 0.18 | |
| Homogeneous metal compounds | 40 | 106.5 | 0.38× | q < 0.0001 | |
| Lipids and lipid-like molecules | 8 | 24.2 | 0.33× | q = 3.9e-4 | |
| Nucleosides, nucleotides, and analogues | 3 | 60.0 | 0.05× | q < 0.0001 | |
| Organic salts | 1 | 0.2 | 4.43× | not tested | |
| Organosulfur compounds | 6 | 4.5 | 1.34× | not tested | |
| Phenylpropanoids and polyketides | 5 | 4.5 | 1.11× | not tested | |
| Mixed metal/non-metal compounds | 1 | 4.6 | 0.22× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 44 |
| DB03530 | CAZ | Acylated ceftazidime | 26 |
| DB03834 | TBE | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine | 22 |
| DB09157 | CO2 | Carbon dioxide | 21 |
| DB04035 | CB4 | Ceftazidime BATSI | 19 |
| DB00142 | GLU | Glutamic acid | 18 |
| DB02145 | 1BO | Butyl alcohol | 13 |
| DB04133 | CED | Degraded Cephaloridine | 13 |
| DB00145 | GLY | Glycine | 12 |
| DB00355 | AZR | Aztreonam | 12 |
| DB08551 | SM2 | 3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid | 12 |
| DB12107 | 4D6 | Vaborbactam | 11 |
| DB00513 | ACA | Aminocaproic acid | 10 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 10 |
| DB04360 | BZB | Benzo[B]Thiophene-2-Boronic Acid | 10 |
| DB00130 | GLN | L-Glutamine | 9 |
| DB09324 | 0RN | Sulbactam | 9 |
| DB15232 | 63J | Telaglenastat | 8 |
| DB00766 | J01 | Clavulanic acid | 7 |
| DB01896 | APB | M-Aminophenylboronic Acid | 7 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 214 |
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 123 |
| NAmetal | SODIUM ION | 71 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 45 |
| ZNmetal | ZINC ION | 41 |
| CDmetal | CADMIUM ION | 40 |
| PNM | OPEN FORM - PENICILLIN G | 39 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 36 |
| 9F2 | Ceftriaxone | 34 |
| TSL | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | 34 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 33 |
| CAmetal | CALCIUM ION | 28 |
| CAZ | ACYLATED CEFTAZIDIME | 27 |
| ID1 | Imipenem | 27 |
| IOD | IODIDE ION | 27 |
| Y33 | (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 27 |
| Kmetal | POTASSIUM ION | 25 |
| CO2 | CARBON DIOXIDE | 24 |
| BAmetal | BARIUM ION | 23 |
| TBE | TAZOBACTAM INTERMEDIATE | 22 |